Published in Obesity and Diabetes Week, October 3rd, 2005
There are currently more than 194 million people with diabetes worldwide and this figure could exceed 333 million by 2025 if untreated. Current treatments for type 2 diabetes are often limited by their side effect profile, route of administration or difficulties in sustaining glucose control. As a result, there is a need for better tolerated treatments that do not cause weight gain and produce less risk of hypoglycemia for patients with type 2 diabetes.
The results of the two Phase II studies indicate that sitagliptin, an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.